AIDS | 2021

Differences in tenofovir trough concentrations between branded and generic formulations in people taking PrEP.

 
 
 
 
 
 
 
 
 
 
 
 

Abstract


Funding: This study was supported by the Natural Science Foundation of China Excellent Young Scientists Fund (82022064), the Natural Science Foundation of China International/Regional Research Collaboration Project (72061137001), Natural Science Foundation of China Young Scientist Fund (81703278), the Australian National Health and Medical Research Commission (NHMRC) Early Career Fellowship (APP1092621), the National Science and Technology Major Project of China (2018ZX10721102), the Sanming Project of Medicine in Shenzhen (SZSM201811071), the High Level Project of Medicine in Longhua, Shenzhen (HLPM201907020105), and the National Key Research andDevelopment Program of China (2020YFC0840900). All funding parties did not have any role in thedesign of the studyor in the explanation of the data. This study was also under the auspices of the Live Water Project of Alibaba Research Institute.

Volume None
Pages None
DOI 10.1097/QAD.0000000000002758
Language English
Journal AIDS

Full Text